| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
First Department of Medicine, Toyama Medical and Pharmaceutical University, Toyama, 930-0194 Japan
Address all correspondence and requests for reprints to: Toshiyasu Sasaoka, M.D., Ph.D., First Department of Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama, 930-0194, Japan. E-mail: tsasaoka-tym{at}umin.ac.jp
To examine the role of SHIP in insulin-induced mitogenic signaling, we
used a truncated SHIP lacking the SH2 domain (
SH2-SHIP) and a
Y917/1020F-SHIP (2F-SHIP) in which two tyrosines contributing to Shc
binding were mutated to phenylalanine. Wild-type (WT)-,
SH2-, and
2F-SHIP were transiently transfected into Rat1 fibroblasts
overexpressing insulin receptors (HIRc). Insulin-stimulated tyrosine
phosphorylation of WT-SHIP and
SH2-SHIP, whereas tyrosine
phosphorylation of 2F-SHIP was not detectable, indicating that
917/1020-Tyr are key phosphorylation sites on SHIP. Although SHIP can
bind via its 917/1020-Tyr residues and SH2 domain to Shc PTB domain and
317-Tyr residue, respectively, insulin-induced SHIP association with
Shc was more greatly decreased in 2F-SHIP cells than that in
SH2-SHIP cells. Insulin stimulation of Shc association with Grb2,
which is important for p21ras-MAP kinase activation, was decreased by
overexpression of WT- and 2F-SHIP. Importantly, insulin-induced
Shc·Grb2 association was not detectably reduced in
SH2-SHIP cells.
In accordance with the extent of Shc association with Grb2,
insulin-induced MAP kinase activation was relatively decreased in both
WT-SHIP and 2F-SHIP cells, but not in
SH2-SHIP cells. To examine the
functional role of SHIP in insulins biological action,
insulin-induced mitogenesis was compared among these transfected cells.
Insulin stimulation of thymidine incorporation and bromodeoxyuridine
incorporation was decreased in WT-SHIP cells compared with that of
control HIRc cells. Expression of 2F-SHIP also significantly reduced
insulin-induced mitogenesis, whereas it was only slightly affected by
overexpression of
SH2-SHIP. Furthermore, the reduction of
insulin-induced mitogenesis in WT-SHIP cells was partly compensated by
coexpression of Shc. These results indicate that SHIP plays a negative
regulatory role in insulin-induced mitogenesis and that the SH2 domain
of SHIP is important for its negative regulatory function.
This article has been cited by other articles:
![]() |
T. Wada, M. Naito, H. Kenmochi, H. Tsuneki, and T. Sasaoka Chronic Nicotine Exposure Enhances Insulin-Induced Mitogenic Signaling via Up-Regulation of {alpha}7 Nicotinic Receptors in Isolated Rat Aortic Smooth Muscle Cells Endocrinology, February 1, 2007; 148(2): 790 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ijuin and T. Takenawa SKIP Negatively Regulates Insulin-Induced GLUT4 Translocation and Membrane Ruffle Formation Mol. Cell. Biol., February 15, 2003; 23(4): 1209 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishihara, T. Sasaoka, M. Ishiki, T. Wada, H. Hori, S. Kagawa, and M. Kobayashi Membrane Localization of Src Homology 2-Containing Inositol 5'-Phosphatase 2 via Shc Association Is Required for the Negative Regulation of Insulin Signaling in Rat1 Fibroblasts Overexpressing Insulin Receptors Mol. Endocrinol., October 1, 2002; 16(10): 2371 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasaoka, M. Ishiki, T. Wada, H. Hori, H. Hirai, T. Haruta, H. Ishihara, and M. Kobayashi Tyrosine Phosphorylation-Dependent and -Independent Role of Shc in the Regulation of IGF-1-Induced Mitogenesis and Glycogen Synthesis Endocrinology, December 1, 2001; 142(12): 5226 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefan, A. Koch, A. Mancini, A. Mohr, K. M. Weidner, H. Niemann, and T. Tamura Src Homology 2-containing Inositol 5-Phosphatase 1 Binds to the Multifunctional Docking Site of c-Met and Potentiates Hepatocyte Growth Factor-induced Branching Tubulogenesis J. Biol. Chem., January 26, 2001; 276(5): 3017 - 3023. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |